-Livemint.com Brussels suggested more burdensome, stringent conditions for the permanent solution than what were agreed as part of interim solution in the 2013 Bali summit Geneva: The European Union (EU) has insisted that India must accept a financial cap on market price support programmes if New Delhi wants a permanent solution for the public stockholding programmes for food security at the Nairobi meeting of the World Trade Organization next week, according...

-The Telegraph Paris: An international forestry research agency has accused the world's biggest users of coal, including India, of continuing their emphasis on coal-fired energy and thus threatening global efforts to curb Earth-warming greenhouse emissions. The Centre for International Forestry Research (CIFOR) has bracketed India with Australia, Canada, Indonesia, Colombia and America as countries whose continued focus on coal is putting more carbon dioxide into the atmosphere. It has said these countries' pursuit...

-The Hindu India says it is ready for a regime of stocktaking of future carbon emissions. In a clear signal that active diplomacy is at work to forge an agreement in Paris based on voluntary pledges, one that is subject to transparent monitoring, India said on Friday that it was ready for a regime of stocktaking of future carbon emissions. The U.S., on its part, said it had “nothing but respect” for...

-PTI United Nations: India has been ranked a low 131 out of 167 nations on a global index that measures the level of information and communication technology access, even as the number of households with Internet and computer has increased in the country over the last five years. UN International Telecommunications Union’s flagship annual Measuring the Information Society Report said that globally 3.2 billion people are now online, representing 43.4 per cent...

-The Times of India NEW DELHI: In a move that comes as a huge relief to patients of chronic Hepatitis C, the apex committee of the Central Drugs Standard Control Organisation (CDSCO) has granted a waiver of local trials for crucial new direct-acting antiviral drugs treating the disease. The waiver for sofosbuvir and ledipasvir co-formulation and for daclatasvir is expected to bring the generic version of these drugs, which cost a fraction...